ADAM17 and diabetic kidney disease: Our observations also align with previous findings that ADAM17 protein expression increased in the kidneys in db/db mice, which was associated with the lower renal expression of an endogenous inhibitor of ADAM17, inhibitor of metalloproteinase 3 (TIMP3), leading to the exacerbation of DKD [36].